Modular Extracellular Matrices: Solutions for the Puzzle

Overview

Journal Methods

Specialty Biochemistry

Date 2008 Apr 30

PMID 18442709

Citations 43

Authors

Monica A Serban

Glenn D Prestwich

Affiliations

Soon will be listed here.

Abstract

The common technique of growing cells in two-dimensions (2-D) is gradually being replaced by culturing cells on matrices with more appropriate composition and stiffness, or by encapsulation of cells in three-dimensions (3-D). The universal acceptance of the new 3-D paradigm has been constrained by the absence of a commercially available, biocompatible material that offers ease of use, experimental flexibility, and a seamless transition from in vitro to in vivo applications. The challenge-the puzzle that needs a solution-is to replicate the complexity of the native extracellular matrix (ECM) environment with the minimum number of components necessary to allow cells to rebuild and replicate a given tissue. For use in drug discovery, toxicology, cell banking, and ultimately in reparative medicine, the ideal matrix would therefore need to be highly reproducible, manufacturable, approvable, and affordable. Herein we describe the development of a set of modular components that can be assembled into biomimetic materials that meet these requirements. These semi-synthetic ECMs, or sECMs, are based on hyaluronan derivatives that form covalently crosslinked, biodegradable hydrogels suitable for 3-D culture of primary and stem cells in vitro, and for tissue formation in vivo. The sECMs can be engineered to provide appropriate biological cues needed to recapitulate the complexity of a given ECM environment. Specific applications for different sECM compositions include stem cell expansion with control of differentiation, scar-free wound healing, growth factor delivery, cell delivery for osteochondral defect and liver repair, and development of vascularized tumor xenografts for personalized chemotherapy.

Citing Articles

Cellular Systems for Colorectal Stem Cancer Cell Research.

Grigoreva T, Kindt D, Sagaidak A, Novikova D, Tribulovich V Cells. 2025; 14(3).

PMID: 39936962 PMC: 11817814. DOI: 10.3390/cells14030170.

Enhancing maturity in 3D kidney micro-tissues through clonogenic cell combinations and endothelial integration.

Abdollahzadeh F, Khoshdel-Rad N, Bahrehbar K, Erfanian S, Ezzatizadeh V, Totonchi M J Cell Mol Med. 2024; 28(11):e18453.

PMID: 38818569 PMC: 11140233. DOI: 10.1111/jcmm.18453.

Applications and Advances of Multicellular Tumor Spheroids: Challenges in Their Development and Analysis.

Mitrakas A, Tsolou A, Didaskalou S, Karkaletsou L, Efstathiou C, Eftalitsidis E Int J Mol Sci. 2023; 24(8).

PMID: 37108113 PMC: 10138394. DOI: 10.3390/ijms24086949.

'Two-faces' of hyaluronan, a dynamic barometer of disease progression in tumor microenvironment.

Liu Y, Li L, Wang L, Lu L, Li Y, Huang G Discov Oncol. 2023; 14(1):11.

PMID: 36698043 PMC: 9877274. DOI: 10.1007/s12672-023-00618-1.

Different Expression of Thyroid-Specific Proteins in Thyroid Cancer Cells between 2-Dimensional (2D) and 3-Dimensional (3D) Culture Environment.

Oh J, Gangadaran P, Rajendran R, Hong C, Lee J, Ahn B Cells. 2022; 11(22).

PMID: 36428988 PMC: 9688357. DOI: 10.3390/cells11223559.

References

Connors R, Muir J, Liu Y, Reiss G, Kouretas P, Whitten M . Postoperative pericardial adhesion prevention using Carbylan-SX in a rabbit model. J Surg Res. 2007; 140(2):237-42. DOI: 10.1016/j.jss.2007.03.014. View

Allison D, Grande-Allen K . Review. Hyaluronan: a powerful tissue engineering tool. Tissue Eng. 2006; 12(8):2131-40. DOI: 10.1089/ten.2006.12.2131. View

Flynn L, Prestwich G, Semple J, Woodhouse K . Adipose tissue engineering with naturally derived scaffolds and adipose-derived stem cells. Biomaterials. 2007; 28(26):3834-42. DOI: 10.1016/j.biomaterials.2007.05.002. View

Duflo S, Thibeault S, Li W, Shu X, Prestwich G . Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng. 2006; 12(8):2171-80. DOI: 10.1089/ten.2006.12.2171. View

Ghosh K, Shu X, Mou R, Lombardi J, Prestwich G, Rafailovich M . Rheological characterization of in situ cross-linkable hyaluronan hydrogels. Biomacromolecules. 2005; 6(5):2857-65. DOI: 10.1021/bm050361c. View

Toole B . Hyaluronan in morphogenesis. J Intern Med. 1997; 242(1):35-40. DOI: 10.1046/j.1365-2796.1997.00171.x. View

Cai S, Liu Y, Shu X, Prestwich G . Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials. 2005; 26(30):6054-67. DOI: 10.1016/j.biomaterials.2005.03.012. View

Pike D, Cai S, Pomraning K, Firpo M, Fisher R, Shu X . Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials. 2006; 27(30):5242-51. DOI: 10.1016/j.biomaterials.2006.05.018. View

Saettone M, Monti D, Torracca M, Chetoni P . Mucoadhesive ophthalmic vehicles: evaluation of polymeric low-viscosity formulations. J Ocul Pharmacol. 1994; 10(1):83-92. DOI: 10.1089/jop.1994.10.83. View

10.

Cima L . Polymer substrates for controlled biological interactions. J Cell Biochem. 1994; 56(2):155-61. DOI: 10.1002/jcb.240560206. View

11.

Liu Y, Shu X, Prestwich G . Reduced postoperative intra-abdominal adhesions using Carbylan-SX, a semisynthetic glycosaminoglycan hydrogel. Fertil Steril. 2006; 87(4):940-8. DOI: 10.1016/j.fertnstert.2006.07.1532. View

12.

Shu X, Ghosh K, Liu Y, Palumbo F, Luo Y, Clark R . Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J Biomed Mater Res A. 2004; 68(2):365-75. DOI: 10.1002/jbm.a.20002. View

13.

Shu X, Liu Y, Palumbo F, Luo Y, Prestwich G . In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials. 2003; 25(7-8):1339-48. DOI: 10.1016/j.biomaterials.2003.08.014. View

14.

Prestwich G . Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach. J Cell Biochem. 2007; 101(6):1370-83. DOI: 10.1002/jcb.21386. View

15.

Hansen J, Thibeault S, Walsh J, Shu X, Prestwich G . In vivo engineering of the vocal fold extracellular matrix with injectable hyaluronic acid hydrogels: early effects on tissue repair and biomechanics in a rabbit model. Ann Otol Rhinol Laryngol. 2005; 114(9):662-70. DOI: 10.1177/000348940511400902. View

16.

Liu Y, Shu X, Prestwich G . Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng. 2007; 12(12):3405-16. DOI: 10.1089/ten.2006.12.3405. View

17.

Liu Y, Shu X, Prestwich G . Tumor engineering: orthotopic cancer models in mice using cell-loaded, injectable, cross-linked hyaluronan-derived hydrogels. Tissue Eng. 2007; 13(5):1091-101. DOI: 10.1089/ten.2006.0297. View

18.

Ghosh K, Ren X, Shu X, Prestwich G, Clark R . Fibronectin functional domains coupled to hyaluronan stimulate adult human dermal fibroblast responses critical for wound healing. Tissue Eng. 2006; 12(3):601-13. DOI: 10.1089/ten.2006.12.601. View

19.

Sondrup C, Liu Y, Shu X, Prestwich G, Smith M . Cross-linked hyaluronan-coated stents in the prevention of airway stenosis. Otolaryngol Head Neck Surg. 2006; 135(1):28-35. DOI: 10.1016/j.otohns.2006.01.018. View

20.

Orlandi R, Shu X, McGill L, Petersen E, Prestwich G . Structural variations in a single hyaluronan derivative significantly alter wound-healing effects in the rabbit maxillary sinus. Laryngoscope. 2007; 117(7):1288-95. DOI: 10.1097/MLG.0b013e318058a083. View